Lume Health says early users of its prototype wearable cortisol monitor spent 27 percent less time awake in bed after adjusting daylight exposure based on their data. The company gave the device its first public preview last Thursday night at "Beyond Burnout: Cortisol, Estrogen & Hormone Imbalance Draining Your Energy," a happy hour and fireside chat hosted at Flying Solo on Broome Street in SoHo, New York. NewBeauty was a media sponsor of the event.

The evening also featured real-time hair follicle testing from OMI WellBeauty x Glamsquad, while guests drank De Soi and OoMee beverages.

The problem Lume is chasing

The discussion targeted a gap most women recognize but struggle to name: fatigue, brain fog and burnout that appear long before a lab test flags anything abnormal. Cortisol, the speakers stressed, is not a single number to lower but a rhythm. It should spike in the morning and taper through the day. Chronic stress, poor sleep and estrogen-linked hormonal shifts can disrupt that pattern, producing the wired-but-tired exhaustion that has become a defining complaint of modern life, particularly for women in perimenopause and menopause.

Current measurement tools fall short. A single blood draw or a saliva kit mailed to a lab captures a snapshot, not the pattern. Lume Health was founded to close that gap.

Founders with hardware credentials

Vicki Powell, a former Apple product design engineer who worked on sensor technology for AirPods, Apple Watch and iPhone and holds her own sensing patents, co-founded the company. Dr. Jonathan Moustakis, an award-winning physician, serves as CTO.

What the prototype does

The Lume wearable cortisol monitor tracks cortisol rhythms continuously throughout the day rather than in one isolated reading. The current version estimates cortisol rhythm from wearable signals calibrated against saliva samples. Future versions aim to read cortisol directly from sweat through integrated sensors.

The device is not intended to replace an Oura Ring or Whoop. Lume positions it as a layer that adds the one biomarker those devices cannot see, then translates it into action: when to get morning light, when real energy peaks and dips occur, and how to time meals and workouts around an individual rhythm instead of a generic protocol.

Early access users are already reporting results. Beyond the 27 percent reduction in time spent awake in bed, some participants described the shift in energy and sleep quality as life-changing, according to Lume.

Timeline and availability

The Lume wearable is in beta development. A full launch is targeted for 2027, and a waitlist is open now at lumehealth.io. The questions that kept Thursday's fireside chat running past its scheduled end suggest real appetite for a device that treats hormonal health as something to understand in real time, not diagnose after the fact.

OMI x Glamsquad test follicles on the spot

The hormone talk was not the only science on offer. OMI WellBeauty, the peptide-based hair growth brand founded by Naomi Whittel, partnered with Glamsquad to run real-time follicle testing for guests at the event.

The tie-in fits OMI's core thesis: most hair loss and thinning stems from peptide depletion at the follicle level, not only genetics or styling damage. OMI's flagship IFP-131 peptide formula, sold in capsules or wild-berry gummies, is designed to anchor and strengthen hair from within. The brand cites clinical results of up to 47 percent less hair loss in 90 days and up to 10 percent more hairs in their growth phase by day 30.

Having Glamsquad examine follicles in real time turned that science from a claim on a bottle into something guests could see for themselves — a tactile argument for a supplement that otherwise asks consumers to take its word for it.

Between the two activations, "Beyond Burnout" addressed burnout as a hormonal story and as something that shows up, quite literally, at the root. With a 2027 launch ahead, Lume's beta data will show whether continuous cortisol tracking can move from prototype to standard practice in hormonal health monitoring.